Stockhead on MSN
Health Kick Podcast: Cynata Therapeutics entering into major stem cell clinical catalysts
Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.
MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025SAN DIEGO, Nov. 02, 2025 (GLOBE ...
TrialWear was invented by Elizabeth Johnson, an assistant professor in MSU’s Mark and Robyn Jones College of Nursing.
The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
Get the latest S&P 500 healthcare stock winners & losers, major earnings beats, profit forecasts, and legal news for key companies.
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company ...
Many cancer types — breast, prostate, skin cancer — have 5-year survival rates and ample treatment options if caught early.
WALL, N.J. and BARANGAROO, Australia, /PRNewswire/ -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through ...
The fresh research, carried out by the University of Queensland in Australia, found that people with MND who experience ...
A new study suggests that psychotherapy delivered through text-based messaging can be as effective as live video sessions for ...
This article reviews the interplay between histamine and serotonin in upper GI motility and highlights three clinical cases. It provides practical insights into assessment, treatment strategies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results